Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies
Serine Avagyan,Akiko Shimamura +1 more
TL;DR: A framework for the evaluation of germline predisposition to MDS across all ages is presented, and characteristics of personal and family history, clinical exam and laboratory findings, and integration of genetic sequencing results are discussed to assist in the diagnostic evaluation.
read more
Abstract: Pediatric myelodysplastic syndromes (MDS) often raise concern for an underlying germline predisposition to hematologic malignancies, referred to as germline predisposition herein. With the availability of genetic testing, it is now clear that syndromic features may be lacking in patients with germline predisposition. Many genetic lesions underlying germline predisposition may also be mutated somatically in de novo MDS and leukemias, making it critical to distinguish their germline origin. The verification of a suspected germline predisposition informs therapeutic considerations, guides monitoring pre- and post-treatment, and allows for family counseling. Presentation of MDS due to germline predisposition is not limited to children and spans a wide age range. In fact, the risk of MDS may increase with age in many germline predisposition conditions and can present in adults who lack classical stigmata in their childhood. Furthermore, germline predisposition associated with DDX41 mutations presents with older adult-onset MDS. Although a higher proportion of pediatric patients with MDS will have a germline predisposition, the greater number of MDS diagnoses in adult patients may result in a larger overall number of those with an underlying germline predisposition. In this review, we present a framework for the evaluation of germline predisposition to MDS across all ages. We discuss characteristics of personal and family history, clinical exam and laboratory findings, and integration of genetic sequencing results to assist in the diagnostic evaluation. We address the implications of a diagnosis of germline predisposition for the individual, for their care after MDS therapy, and for family members. Studies on MDS with germline predisposition have provided unique insights into the pathogenesis of hematologic malignancies and mechanisms of somatic genetic rescue vs. disease progression. Increasing recognition in adult patients will inform medical management and may provide potential opportunities for the prevention or interception of malignancy.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Myelodysplastic syndromes.
TL;DR: Therapeutic goals in people with higher-risk MDS include decreasing the risk of AML transformation and prolonging survival, and how, when and in which patients with HCT for MDS should be performed remains controversial.
38
Myelodysplastic neoplasms: An overview on diagnosis, risk-stratification, molecular pathogenesis, and treatment.
TL;DR: In this paper , the Revised International Prognostic Scoring System (RIPS) was used to assess the risk of myelodysplastic neoplasms (MDS).
7
Optimizing diagnostic methods and stem cell transplantation outcomes in pediatric bone marrow failure: a 50-year single center experience.
TL;DR: Management guidelines and HSCT outcomes of pediatric BMF patients to pinpoint improvements and future challenges and comprehensive approach to identify the cause of BMF can prevent treatment delay and be useful to tailor treatment and follow-up protocols are reported on.
4
Germline Predisposition to Myeloid Neoplasms: Diagnostic Concepts and Classifications.
Ifeyinwa E. Obiorah,Kalpana Upadhyaya,Katherine R. Calvo +2 more
TL;DR: Recognition of myeloid malignancy associated with germline mutations is essential for proper therapy, disease surveillance, informing related donor selection for hematopoietic stem cell transplantation, and genetic counseling of the patient and affected family members.
3
The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition
TL;DR: A review of changes in the recently published classifications of AML and myelodysplastic syndrome, emerging prognostic scoring, and the role of germline deleterious variants in predisposing to MDS and AML can be found in this paper .
3
References
Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia.
Fan Dong,David C. Dale,Mary Ann Bonilla,Matthew L. Freedman,A. Fasth,H. J. Neijens,Jan Palmblad,G. L. Briars,Göran Carlsson,Anjo J.P. Veerman,Karl Welte,Bob Löwenberg,Ivo P. Touw +12 more
TL;DR: Support is added to the notion that mutations in the G-CSF-R gene, affecting the maturation signaling function of the receptor, define a distinct subgroup of SCN with increased susceptibilty to AML.
Recognition of familial myeloid neoplasia in adults.
TL;DR: Clinicians and pathologists will need to have a high index of suspicion and be familiar with the aspects of a patient's personal or family history that should raise suspicion regarding these syndromes as well as the options for clinical testing.
Monosomy 7 in Pediatric Myelodysplastic Syndromes.
TL;DR: Insight is provided into the current understanding of the genotype, phenotype, and clonal evolution patterns in pediatric MDS associated with loss of chromosome 7.
Deletion of chromosome 20 in bone marrow of patients with Shwachman-Diamond syndrome, loss of the EIF6 gene and benign prognosis
Barbara Pressato,Roberto Valli,Cristina Marletta,Lydia Mare,Giuseppe Montalbano,Francesco Lo Curto,Francesco Pasquali,Emanuela Maserati +7 more
TL;DR: Evidence for a role of anti-ADAMts13 autoantibodies despite normal ADAMTS13 activity in recurrent thrombotic thromBocytopenic purpura is found and a study of the safety and efficacy of eculizumab in aHUS patients resistant to plasma therapy is published.
An in vivo genetic reversion highlights the crucial role of Myb-Like, SWIRM, and MPN domains 1 (MYSM1) in human hematopoiesis and lymphocyte differentiation.
Tangui Le Guen,Tangui Le Guen,Fabien Touzot,Fabien Touzot,Fabien Touzot,Isabelle André-Schmutz,Isabelle André-Schmutz,Chantal Lagresle-Peyrou,Chantal Lagresle-Peyrou,Laetitia Kermasson,Laetitia Kermasson,Nathalie Lambert,Capucine Picard,Capucine Picard,Patrick Nitschke,Wassila Carpentier,Christine Bole-Feysot,Annick Lim,Marina Cavazzana,Isabelle Callebaut,Jean Soulier,Nada Jabado,Alain Fischer,Alain Fischer,Jean-Pierre de Villartay,Jean-Pierre de Villartay,Patrick Revy,Patrick Revy +27 more
TL;DR: A patient presenting with a complete lack of B lymphocytes, T-cell lymphopenia, defective hematopoiesis, and developmental abnormalities is described and evidence that MYSM1 is essential for proper immunohematopoietic development in human subjects is provided.